LICENSING AND SUPPLY AGREEMENTLicensing and Supply Agreement • November 28th, 2005 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances)
THIS LICENSING AND SUPPLY AGREEMENT (this “Agreement”), effective as of this 31st day of October, 2005 (the “Effective Date”), is by and among GTC Biotherapeutics, Inc., a corporation organized under the laws of the Commonwealth of Massachusetts with its principal offices at 175 Crossing Boulevard, Suite 410, Framingham, Massachusetts 01702 (“GTC”), and ATIII LLC, a limited liability company organized under the laws of the State of Delaware having its principal place of business at 175 Crossing Boulevard, Framingham, Massachusetts 01702 which is a wholly owned (100%) subsidiary of GTC, (“ATIII LLC”), and LEO Pharma A/S, a corporation organized under the laws of Denmark, with its principal offices at Industriparken 55, DK-2750 Ballerup, Denmark (“LEO”). LEO, ATIII LLC and GTC may be referred to herein individually as a “Party” or collectively as the “Parties.”
